Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning

BACKGROUND: In 2016, the first global viral hepatitis elimination targets were endorsed. An estimated one-third of the world’s population of individuals with chronic hepatitis B virus (HBV) infection live in China and liver cancer is the sixth leading cause of mortality, but coverage of first-line a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayagam, Shevanthi, Chan, Polin, Zhao, Kun, Sicuri, Elisa, Wang, Xiaochun, Jia, Jidong, Wei, Lai, Walsh, Nick, Rodewald, Lance E, Zhang, Guomin, Ailing, Wang, Zhang, Lan, Chang, Joo H, Hou, WeiWei, Qiu, Yingpeng, Sui, Binyan, Xiao, Yue, Zhuang, Hui, Thursz, M R, Scano, Fabio, Low-Beer, Daniel, Schwartländer, Bernhard, Wang, Yu, Hallett, Timothy B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935389/
https://www.ncbi.nlm.nih.gov/pubmed/32255486
http://dx.doi.org/10.1093/cid/ciaa134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935389/
https://www.ncbi.nlm.nih.gov/pubmed/32255486
http://dx.doi.org/10.1093/cid/ciaa134

Ejemplares similares